Explore more publications!
Africa News Guide
Got News to Share?

Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 30, 2026

Taseko to Release First Quarter 2026 Results
Apr. 30, 2026

Taseko to Release First Quarter 2026 Results

Indeterminate GlobeNewswire
غرينبيس الشرق الأوسط وشمال أفريقيا: اعتراض وتهديد إسرائيل لأسطول الصمود بالمياه الدولية انتهاك للقانون الدولي الإنساني
Apr. 30, 2026

غرينبيس الشرق الأوسط وشمال أفريقيا: اعتراض وتهديد إسرائيل لأسطول الصمود بالمياه الدولية انتهاك للقانون الدولي الإنساني

Indeterminate EIN Presswire
Belo Sun Provides Update on Volta Grande Gold Project
Apr. 30, 2026

Belo Sun Provides Update on Volta Grande Gold Project

Indeterminate GlobeNewswire
Odurinde eLearning and Hope Spring eCards Launch Collaboration Focused on Digital Skills and Social Impact
Apr. 30, 2026

Odurinde eLearning and Hope Spring eCards Launch Collaboration Focused on Digital Skills and Social Impact

Indeterminate EIN Presswire
TLX101-Px (Pixlumi®) MAA Accepted in Europe
Apr. 30, 2026

TLX101-Px (Pixlumi®) MAA Accepted in Europe

Indeterminate GlobeNewswire
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
Apr. 30, 2026

Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
ExGen Signs Purchase Agreement to Acquire Lithium Properties in Nevada
Apr. 30, 2026

ExGen Signs Purchase Agreement to Acquire Lithium Properties in Nevada

Indeterminate GlobeNewswire
Cue Biopharma Announces $30 Million Private Placement
Apr. 30, 2026

Cue Biopharma Announces $30 Million Private Placement

Indeterminate GlobeNewswire
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
Apr. 30, 2026

Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody

Indeterminate GlobeNewswire
Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
Apr. 30, 2026

Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
Apr. 30, 2026

Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection

Indeterminate GlobeNewswire
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
Apr. 30, 2026

Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions

Indeterminate GlobeNewswire
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
Apr. 30, 2026

Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company

Indeterminate GlobeNewswire
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
Apr. 30, 2026

PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June

Indeterminate GlobeNewswire
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
Apr. 30, 2026

Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Globit and TradeAssets Join Forces to Strengthen FI Risk Management for Banks
Apr. 30, 2026

Globit and TradeAssets Join Forces to Strengthen FI Risk Management for Banks

Indeterminate EIN Presswire
Ensuring Technical Precision and Cultural Alignment in International Document Management
Apr. 30, 2026

Ensuring Technical Precision and Cultural Alignment in International Document Management

Indeterminate EIN Presswire
EnGeneIC Announces First Patient Dosed in Recurrent Glioblastoma Clinical Trial
Apr. 30, 2026

EnGeneIC Announces First Patient Dosed in Recurrent Glioblastoma Clinical Trial

Indeterminate GlobeNewswire
AbbVie et adMare BioInnovations nomment RIME Therapeutics lauréat du Prix AbbVie des innovateurs en biotechnologies au Québec
Apr. 30, 2026

AbbVie et adMare BioInnovations nomment RIME Therapeutics lauréat du Prix AbbVie des innovateurs en biotechnologies au Québec

Indeterminate GlobeNewswire
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
Apr. 30, 2026

AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions